Ultragenyx Pharmaceutical Inc. (RARE) Earnings
NASDAQ·Healthcare·Biotechnology
$25.03
-3.66%
Mkt Cap $2.56B
EPS — Estimate vs Actual
Mkt Cap
$2.56B
P/E
—
Fwd P/E
—
P/S
3.82
Rev TTM
—
EPS TTM
-$6.11
NASDAQ·Healthcare·Biotechnology
$25.03
-3.66%
Mkt Cap $2.56B
Mkt Cap
$2.56B
P/E
—
Fwd P/E
—
P/S
3.82
Rev TTM
—
EPS TTM
-$6.11